Background
Methods
Study population
Clinical, anthropometric and laboratory measurements
Definition of variables and outcomes
Statistical analyses
Results
Study participants and baseline characteristics
Variables | Total n = 8238 | Gender difference | p-value | |
---|---|---|---|---|
Men n = 3795 | Women n = 4443 | |||
Age (years) | 39.3 (13.3) | 41.4 (14.2) | 37.5 (12.1) | 0.001 |
Total length of stay in the city (years) | 32.9 (13.1) | 34.6 (13.2) | 31.5 (12.8) | 0.001 |
BMI (kg/m2) | 26.5 (4.7) | 25.8 (4.1) | 27.1 (5.1) | 0.001 |
Waist circumference (cm) | 87.4 (12.3) | 89.1 (11.5) | 86.1 (12.8) | 0.001 |
Wrist circumference (cm) | 16.7 (1.3) | 17.7 (0.9) | 15.9 (1.1) | 0.001 |
Hip circumference (cm) | 100.29 (9.17) | 96.71 (7.23) | 103.43 (9.54) | 0.001 |
FPG (mmol/l) | 4.9 (4.6–5.4) | 5.1 (4.7–5.4) | 4.9 (4.5–5.3) | 0.001 |
TG (mmol/l) | 1.5 (1.1–2.3) | 1.7 (1.2–2.5) | 1.4 (0.9–2.1) | 0.001 |
TC (mmol/l) | 5.2 (1.1) | 5.1 (1.1) | 5.2 (1.2) | 0.07 |
HDL-C (mmol/l) | 1.1 (0.3) | 0.9 (0.2) | 1.2 (0.3) | 0.001 |
eGFR (ml/min/1.73 m2) | 75.6 (10.5) | 77.1 (10.8) | 74.3 (10.1) | 0.001 |
SBP (mmHg) | 116.5 (17.1) | 118.8 (16.7) | 114.6 (17.1) | 0.001 |
DBP (mmHg) | 76.4 (10.6) | 77.1(10.7) | 75.8 (10.5) | 0.001 |
Heart rate (beats/min) | 79.3 (11.5) | 75.3 (9.8) | 82.7 (11.7) | 0.001 |
Education | ||||
Level 1 (illiterate) | 1754 (21.3) | 739 (19.5) | 1015 (22.8) | |
Level 2 (< 9 years) | 4831 (58.6) | 2228 (58.7) | 2603 (58.6) | 0.001 |
Level 3 (9–12 years) | 1203 (14.6) | 688 (18.1) | 515 (11.6) | |
Level 4 (> 12 years) | 450 (5.5) | 140 (3.7) | 310 (7.0) | |
Marital status | ||||
Single | 1337 (16.2) | 743 (19.6) | 594 (13.4) | |
Married | 6625 (80.4) | 3027 (79.8) | 3598 (81.0) | 0.001 |
Divorced/widowed | 276 (3.4) | 25 (0.7) | 251 (5.6) | |
FH-CVD in female relatives | 669 (8.1) | 267 (7.0) | 402 (9.0) | 0.001 |
FH-CVD in male relatives | 657 (8.0) | 310 (8.2) | 347 (7.8) | 0.568 |
FHD in first-degree relatives | 2255 (27.4) | 977 (25.7) | 1278 (28.8) | 0.002 |
PAL | ||||
Inactivea
| 5458 (66.3) | 2533 (66.7) | 2925 (65.8) | 0.802 |
Smoking | ||||
Never | 6207 (75.3) | 2067 (54.5) | 4140 (93.2) | |
Past | 567 (6.9) | 510 (13.4) | 57 (1.3) | 0.001 |
Current | 1339 (16.3) | 1158 (30.5) | 181 (4.1) | |
Use of blood lipid lowering drugs | 177 (2.1) | 63 (1.7) | 114 (2.6) | 0.005 |
Use of blood glucose lowering drugs | 234 (2.8) | 100 (2.6) | 134 (3.0) | 0.319 |
Use of anti hypertensive drugs | 335 (4.1) | 113 (3.0) | 222 (5.0) | 0.001 |
Use of aspirin | 717 (8.7) | 394 (10.4) | 323 (7.3) | 0.001 |
Use of diuretics | 93 (1.1) | 22 (0.6) | 71 (1.6) | 0.001 |
Prevalence CVD | 219 (2.7) | 140 (3.7) | 79 (1.8) | 0.001 |
Variables | Total n = 10,333 | Followed n = 8238 | Non-followed n = 2095 | Difference (95% CI) |
---|---|---|---|---|
Age (years) | 39.24 (13.64) | 39.29 (13.25) | 39.02 (15.07) | 0.27 (− 0.38, 0.92) |
Total length of stay in the city (years) | 32.68 (13.47) | 32.88 (13.08) | 31.88 (14.90) | 1.00 (0.30, 1.69) |
BMI (kg/m2) | 26.44 (4.77) | 26.50 (4.67) | 26.20 (5.14) | 0.29 (0.04, 0.54) |
Waist circumference (cm) | 87.23 (12.38) | 87.42 (12.28) | 86.47 (12.75) | 0.95 (0.33, 1.56) |
Wrist circumference (cm) | 16.69 (1.34) | 16.71 (1.34) | 16.64 (1.32) | 0.07 (0.01, 0.13) |
Hip circumference (cm) | 100.18 (9.34) | 100.28 (9.17) | 99.78 (9.98) | 0.50 (0.02, 0.98) |
FPG (mmol/l) | 5.29 (1.59) | 5.27 (1.53) | 5.38 (1.83) | − 0.10 (− 0.19, − 0.01) |
TG (mmol/l) | 1.83 (1.33) | 1.84 (1.34) | 1.80 (1.33) | 0.04 (− 0.02, 0.11) |
TC (mmol/l) | 5.16 (1.15) | 5.17 (1.14) | 5.11 (1.17) | 0.05 (0.01, 0.11) |
HDL-C (mmol/l) | 1.07 (0.28) | 1.07 (0.28) | 1.07 (0.28) | − 0.00 (− 0.01, 0.01) |
eGFR (mL/min/1.73 m2) | 75.70 (10.53) | 75.59 (10.49) | 76.15 (10.70) | − 0.56 (− 1.07, − 0.04) |
SBP (mmHg) | 116.59 (17.40) | 116.49 (17.05) | 116.99 (18.74) | − 0.50 (− 1.33, 0.34) |
DBP (mmHg) | 76.34 (10.65) | 76.39 (10.60) | 76.15 (10.81) | 0.23 (− 0.27, 0.75) |
Heart rate (beats/min) | 79.28 (11.54) | 79.25 (11.50) | 79.40 (11.71) | − 0.15 (− 0.71, 0.40) |
Educationa
| ||||
Level 1 (illiterate) | 2202 (21.3) | 1754 (21.3) | 448 (21.4) | 0.0086 (− 0.0119, 0.0289) |
Level 2 (< 9 years) | 6000 (58.1) | 4831 (58.6) | 1169 (55.8) | |
Level 3 (9–12 years) | 1520 (14.7) | 1203 (14.6) | 317 (15.1) | |
Level 4 (> 12 years) | 611 (5.9) | 450 (5.5) | 161 (7.7) | |
Marital status | ||||
Single | 1814 (17.6) | 1337 (16.2) | 477 (22.8) | 0.0759 (0.0540, 0.0979) |
Married | 8149 (78.9) | 6625 (80.4) | 1524 (72.7) | |
Divorced/widowed | 370 (3.6) | 276 (3.4) | 94 (4.5) | |
FH-CVD in female relatives | 840 (8.1) | 669 (8.1) | 171 (8.2) | − 0.0009 (− 0.0293, 0.0275) |
FH-CVD in male relatives | 843 (8.2) | 657 (8.0) | 186 (8.9) | − 0.019 (− 0.048, 0.009) |
FHD in first-degree relatives | 2801 (27.1) | 2255 (27.4) | 546 (26.1) | 0.0107 (− 0.0066, 0.0280) |
PAL | ||||
Inactiveb
| 6827 (70.5) | 5458 (70.7) | 1369 (69.9) | − 0.0063 (− 0.0239, 0.0114) |
Smoking | ||||
Never | 7684 (75.6) | 6207 (76.5) | 1477 (72.1) | − 0.0001 (− 0.0305, 0.0304) |
Past | 702 (6.9) | 567 (7.0) | 135 (6.6) | |
Current | 1776 (17.5) | 1339 (16.5) | 437 (21.3) | |
Use of blood lipid lowering drugs | 231 (2.2) | 177 (2.1) | 54 (2.6) | − 0.0317 (− 0.0869, 0.0234) |
Use of blood glucose lowering drugs | 320 (3.1) | 234 (2.8) | 86 (4.1) | − 0.0681 (− 0.1173, − 0.0189) |
Use of anti hypertensive drugs | 434 (4.2) | 335 (4.1) | 99 (4.7) | − 0.0265 (− 0.0667, 0.0138) |
Use of aspirin | 933 (9.0) | 717 (8.7) | 216 (10.3) | − 0.0316 (− 0.0599, -0.0034) |
Use of diuretics | 120 (1.2) | 93 (1.1) | 27 (1.3) | − 0.0225 (− 0.0976, 0.0526) |
Prevalence CVD | 324 (3.1) | 219 (2.7) | 105 (5.0) | − 0.1253 (− 0.1768, -0.0737) |
Variables | Men | Women | ||||
---|---|---|---|---|---|---|
Non CKD n = 3002 | Incident CKD n = 793 | p-value | Non CKD n = 2928 | Incident CKD n = 1515 | p-value | |
Age (years) | 39.1 (13.3) | 50.3 (13.6) | < 0.001 | 34.2 (10.6) | 43.8 (12.4) | < 0.001 |
Total length of stay in the city (years) | 33.1 (12.5) | 40.3 (14.1) | < 0.001 | 28.9 (11.7) | 36.5 (13.59) | < 0.001 |
BMI (kg/m2) | 25.7 (4.2) | 26.3 (3.9) | < 0.001 | 26.6 (5.1) | 28.1 (4.8) | < 0.001 |
Waist circumference (cm) | 88.5 (11.5) | 90.9 (11.1) | < 0.001 | 84.5 (12.7) | 88.9 (12.5) | < 0.001 |
Wrist circumference (cm) | 17.6 (0.9) | 17.8 (0.9) | < 0.001 | 15.7 (1.1) | 16.1 (1.1) | < 0.001 |
Hip circumference (cm) | 96.6 (7.3) | 97.1 (7.1) | 0.086 | 102.8 (9.5) | 104.6 (9.4) | < 0.001 |
FPG (mmol/l) | 4.9 (4.7–5.5) | 5.2 (4.8–5.7) | < 0.001 | 4.8 (4.5–5.2) | 4.9 (4.7–5.5) | < 0.001 |
TG (mmol/l) | 1.7(1.1–2.5) | 1.8(1.3–2.6) | < 0.001 | 1.3(0.9–1.9) | 1.6 (1.1–2.3) | < 0.001 |
TC (mmol/l) | 5.1 (1.1) | 5.3 (1.1) | < 0.001 | 5.1 (1.1) | 5.5 (1.3) | < 0.001 |
HDL-C (mmol/l) | 0.9 (0.2) | 0.9 (0.2) | 0.48 | 1.1 (0.3) | 1.2 (0.3) | 0.210 |
eGFR (mL/min/1.73 m2) | 79.2(10.6) | 69.2 (7.4) | < 0.001 | 77.1 (10.1) | 68.8 (7.1) | < 0.001 |
SBP (mmHg) | 117.1 (15.4) | 125.2 (19.7) | < 0.001 | 111.8 (14.9) | 120.1 (19.6) | < 0.001 |
DBP (mmHg) | 76.3 (10.3) | 80.1(11.6) | < 0.001 | 74.6 (10.1) | 78.2 (10.8) | < 0.001 |
Heart rate (beats/min) | 75.5 (9.8) | 74.47 (10.1) | 0.015 | 83.5(11.8) | 81.1 (11.4) | < 0.001 |
Education | ||||||
Level 1 (illiterate) | 518 (17.3) | 221 (27.9) | 560 (19.1) | 455 (30.0) | ||
Level 2 (< 9 years) | 1858 (61.9) | 370 (46.7) | < 0.001 | 1884 (64.3) | 719 (47.5) | < 0.001 |
Level 3 (9–12 years) | 528 (17.6) | 160 (20.2) | 361 (12.3) | 154 (10.2) | ||
Level 4 (> 12 years) | 98 (3.3) | 42 (5.3) | 123 (4.2) | 187 (12.3) | ||
Marital status | ||||||
Single | 686 (22.9) | 57 (7.2) | 503 (17.2) | 91 (6.0) | ||
Married | 2302 (76.7) | 725 (91.4) | < 0.001 | 2325 (79.4) | 1273 (84.0) | < 0.001 |
Divorced/widowed | 14 (0.5) | 11 (1.4) | 100 (3.4) | 151 (10.0) | ||
FH-CVD in female relatives | 200 (6.7) | 67 (8.4) | 0.080 | 244 (8.3) | 158 (10.4) | 0.021 |
FH-CVD in male relatives | 256 (8.5) | 54 (6.8) | 0.116 | 213 (7.3) | 134 (8.8) | 0.064 |
FHD in first-degree relatives | 783 (26.1) | 194 (24.5) | 0.354 | 822 (28.1) | 456 (30.1) | 0.157 |
PAL | ||||||
Inactivea
| 2009 (71.2) | 524 (69.4) | 0.331 | 1908 (70.4) | 1017 (70.9) | 0.716 |
Smoking | ||||||
Never | 1630 (55.1) | 437 (56.2) | 0.001 | 2747 (95.1) | 1393 (93.6) | |
Past | 378 (12.8) | 132 (17.0) | 33 (1.1) | 24 (1.6) | 0.101 | |
Current | 950 (32.1) | 208 (26.8) | 109 (3.8) | 72 (4.8) | ||
Use of blood lipid lowering drugs | 41 (1.4) | 22 (2.8) | 0.006 | 49 (1.7) | 65 (4.3) | < 0.001 |
Use of blood glucose lowering drugs | 55 (1.8) | 45 (5.7) | < 0.001 | 54 (1.8) | 80 (5.3) | < 0.001 |
Use of anti hypertensive drugs | 59 (2.0) | 54 (6.8) | < 0.001 | 90 (3.1) | 132 (8.7) | < 0.001 |
Use of aspirin | 286 (9.5) | 108 (13.6) | 0.001 | 172 (5.9) | 151 (10.0) | < 0.001 |
Use of diuretics | 12 (0.4) | 10 (1.3) | 0.004 | 37 (1.3) | 34 (2.2) | 0.013 |
Prevalence CVD | 87 (2.9) | 53 (6.7) | < 0.001 | 30 (1.0) | 49 (3.2) | < 0.001 |
Predictors of incident CKD in men according to Cox model
Variables | HRs | 95% Confidence interval | p-value |
---|---|---|---|
Men | |||
Age (years) | 1.04 | 1.03–1.05 | < 0.001 |
eGFR (ml/min/1.73 m2) | 0.90 | 0.89–0.91 | < 0.001 |
FPG (mmol/l) | 1.10 | 1.05–1.16 | < 0.001 |
DBP (mmHg) | 1.02 | 1.01–1.03 | < 0.001 |
TC (mmol/l) | 0.89 | 0.83–0.96 | 0.0025 |
Waist circumference (cm) | 0.98 | 0.97–0.99 | 0.016 |
Hip circumference (cm) | 1.02 | 1.00–1.03 | 0.075 |
Heart rate (beats/min) | 0.99 | 0.99–1.00 | 0.093 |
Education | |||
Level 1 (illiterate) | Reference | ||
Level 2 (< 9 years) | 1.18 | 0.83–1.67 | 0.34 |
Level 3 (9–12 years) | 1.24 | 0.87–1.78 | 0.23 |
Level 4 (> 12 years) | 1.56 | 1.06–2.28 | 0.021 |
Marital status | |||
Married | Reference | ||
Single | 1.06 | 0.77–1.47 | 0.70 |
Divorced/widowed | 2.04 | 1.09–3.84 | 0.025 |
FH–CVD in female relatives | |||
No | Reference | ||
Yes | 1.25 | 0.97–1.62 | 0.080 |
PAL | |||
Inactivea
| Reference | ||
Active | 1.21 | 1.03–1.42 | 0.016 |
Smoking | |||
Never | Reference | ||
Past | 1.06 | 0.87–1.30 | 0.51 |
Current | 1.24 | 1.03–1.48 | 0.017 |
Use of blood glucose lowering drugs | |||
No | Reference | ||
Yes | 1.59 | 1.08–2.35 | 0.017 |
Use of aspirin | |||
No | Reference | ||
Yes | 0.84 | 0.67–1.04 | 0.116 |
Women | |||
Age (years) | 1.02 | 1.02–1.03 | < 0.001 |
eGFR (mL/min/10.73 m2) | 0.91 | 0.91–0.92 | < 0.001 |
FPG (mmol/L) | 1.05 | 1.02–1.08 | < 0.001 |
Heart rate (beats/min) | 0.99 | 0.98–0.99 | < 0.001 |
Waist circumference (cm) | 0.99 | 0.98–0.99 | 0.002 |
SBP (mmHg) | 1.01 | 1.00–1.01 | 0.028 |
Wrist circumference (cm) | 1.05 | 1.00–1.01 | 0.119 |
FHD in first-degree relatives | |||
No | Reference | ||
Yes | 0.90 | 0.79–1.01 | 0.08 |
Prevalence CVD | |||
No | Reference | ||
Yes | 1.35 | 0.99–1.82 | 0.048 |
Predictors of incident CKD in women according to Cox model
Predictors of incident CKD in whole population according to Cox model
Variables | HR | 95% CI | p-value |
---|---|---|---|
Gender | |||
Male | Reference | ||
Female | 2.09 | 1.82–2.39 | < 0.001 |
Age (years) | 1.03 | 1.02–1.03 | < 0.001 |
eGFR (ml/min/1.73 m2) | 0.91 | 0.90–0.92 | < 0.001 |
Waist circumference (cm) | 0.99 | 0.98–0.99 | < 0.001 |
FPG (mmol/l) | 1.06 | 1.03–1.09 | < 0.001 |
Heart rate (beats/min) | 0.99 | 0.98–0.99 | < 0.001 |
TC (mmol/l) | 0.95 | 0.91–0.99 | 0.043 |
DBP (mmHg) | 1.01 | 1.00–1.01 | 0.045 |
SBP (mmHg) | 1.00 | 0.99–1.00 | 0.056 |
Wrist circumference (cm) | 1.05 | 0.99–1.10 | 0.077 |
Education | |||
Level 1 (illiterate) | Reference | ||
Level 2 (< 9 years) | 1.05 | 0.89–1.24 | 0.541 |
Level 3 (9–12 years) | 1.11 | 0.92–1.33 | 0.255 |
Level 4 (> 12 years) | 1.41 | 1.14–1.72 | 0.001 |
Marital status | |||
Married | Reference | ||
Single | 0.90 | 0.74–1.09 | 0.312 |
Divorced/widowed | 1.19 | 0.99–1.42 | 0.057 |
FHD in first-degree relatives | |||
No | Reference | ||
Yes | 0.90 | 0.82–0.99 | 0.045 |
Use of blood glucose lowering drugs | |||
No | Reference | ||
Yes | 1.22 | 0.96–1.56 | 0.097 |
PAL | |||
Inactivea
| Reference | ||
Active | 1.09 | 0.99–1.20 | 0.064 |
Prevalence CVD | |||
No | Reference | ||
Yes | 1.25 | 1.01–1.54 | 0.035 |
Survival tree in men
Nodes | Number of cases/number of events | Pattern description | HRs (95% CI) | p-value |
---|---|---|---|---|
15 | 331/8 | eGFR > 74 ml/min/1.73 m2, age ≤ 46 year, PAL < 600 MET, WC ≤ 100 cm, FPG ≤ 4.7 mmol/l | Reference | – |
4 | 110/58 | eGFR ≤ 63.4 ml/min/1.73 m2, age ≤ 50 year | 34.67 (16.54–72.65) | < 0.001 |
5 | 192/130 | eGFR ≤ 63.4 ml/min/1.73 m2, age > 50 year | 70.68 (34.57–144.52) | < 0.001 |
7 | 432/130 | 63.4 < eGFR ≤ 74 ml/min/1.73 m2, age ≤ 50 year | 14.91 (7.30–30.45) | < 0.001 |
8 | 365/172 | 63.4 < eGFR ≤ 74 ml/min/1.73 m2, age > 50 year | 35.82 (17.61–72.85) | < 0.001 |
11 | 368/62 | 70 < eGFR ≤ 74 ml/min/1.73 m2, age ≤ 46 year | 7.48 (3.58–15.62) | < 0.001 |
16 | 771/39 | eGFR > 74 ml/min/1.73 m2, age ≤ 46 year, PAL < 600 MET, WC ≤ 100 cm, FPG > 4.7 mmol/l | 2.16 (1.01–4.63) | < 0.05 |
17 | 143/14 | eGFR > 74 ml/min/1.73 m2, age ≤ 46 year, PAL < 600 MET, WC > 100 cm | 4.67 (1.95–11.13) | < 0.001 |
18 | 481/27 | eGFR > 74 ml/min/1.73 m2, age ≤ 46 year, PAL ≥ 600 MET | 3.02 (1.37–6.67) | < 0.001 |
20 | 237/37 | eGFR > 70 ml/min/1.73 m2, age > 46 year, SBP ≤ 119 mmHg | 8.63 (4.02–18.55) | < 0.001 |
22 | 262/75 | eGFR > 70 ml/min/1.73 m2, age > 46 year, SBP > 119 mmHg, FPG ≤ 5.8 mmol/l | 15.47 (7.46–32.08) | < 0.001 |
23 | 103/41 | eGFR > 70 ml/min/1.73 m2, age > 46 year, SBP > 119 mmHg, FPG > 5.8 mmol/l | 27.26 (12.77–58.18) | < 0.001 |
Survival tree in women
Nodes | Number of cases/number of events | Pattern description | HRs (95% CI) | p-value |
---|---|---|---|---|
12 | 750/43 | Age ≤ 45 year, eGFR > 83.5 ml/min/1.73 m2
| Reference | – |
4 | 419/247 | Age ≤ 45 year, eGFR ≤ 65 ml/min/1.73 m2
| 15.18 (10.97–20.99) | < 0.001 |
6 | 157/41 | Age ≤ 29 year, 65 ≤ eGFR ≤ 71 ml/min/1.73 m2
| 5.07 (3.30–7.77) | < 0.001 |
7 | 549/220 | 29 ≤ Age ≤ 45 year, 65 ≤ eGFR ≤ 71 ml/min/1.73 m2
| 8.78 (6.32–12.15) | < 0.001 |
9 | 656/166 | Age ≤ 45 year, 71 ≤ eGFR ≤ 76 ml/min/1.73 m2
| 4.93 (3.52–6.90) | < 0.001 |
11 | 799/124 | Age ≤ 45 year, 75 ≤ eGFR ≤ 83.5 ml/min/1.73 m2
| 2.72 (1.92–3.86) | < 0.001 |
15 | 152/74 | 45 ≤ Age < 48 year, eGFR ≤ 69 ml/min/1.73 m2
| 12.06 (8.28–17.57) | < 0.001 |
16 | 580/423 | Age > 48 year, eGFR ≤ 69 ml/min/1.73 m2
| 27.25 (19.88–37.34) | < 0.001 |
18 | 241/97 | Age > 45 year, eGFR > 69 ml/min/1.73 m2, SBP ≤ 133 mmHg | 8.95 (6.25–12.82) | < 0.001 |
19 | 140/80 | Age > 45 year, eGFR > 69 ml/min/1.73 m2, SBP > 133 mmHg | 16.41(11.32–23.80) | < 0.001 |